12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAnitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares incre
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersIGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDA
Express News | Amex Halt Add Info Lst 1.660000
CureVac, Oragenics, IGM Biosciences Among Healthcare Movers
Express News | Amex Halt Add Info Lst 2.520000
Express News | Oragenics Appoints William “Frank” Peacock Md as Chief Clinical Officer
Oragenics Appoints William "Frank" Peacock MD as Chief Clinical Officer
Oragenics Appoints William "Frank" Peacock MD as Chief Clinical Officer Download as PDF May 22, 2024Dr. Peacock to Oversee Upcoming Phase II Clinical Trial for Treating Concussion in the Emergency
PTC Therapeutics, Oragenics, GT Biopharma Among Healthcare Movers
Oragenics OGEN Webinar; Dermata DRMA Warrants Exercise
OGEN, BWEN and SINT Among Mid-day Movers
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine Download as PDF May 17, 2024SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering phar
Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise
Oragenics (OGEN) said Thursday that it is preparing to start a phase 2 clinical trial for its potential intranasal treatment for concussion, ONP-002. The company said it has secured an ample supply of
Express News | Oragenics, Inc. Prepares Intranasal Pharmaceutical, Onp-002, for Phase II Concussion Trial
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial Download as PDF May 16, 2024SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE Ameri
Oragenics | 10-Q: Quarterly report
FFIE, OGEN and CCLD Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersCareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.6
Oragenics Inc Reports SEC Filing Update
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov
Express News | Oragenics Shares Are Trading Higher After the Company Announced a Partnership With Avance Clinical to Conduct a Phase II Clinical Trial in Australia
No Data